APPLICATION
ANDA075994
TYPE
ANDA
ORIGINAL APPROVAL
2002-07-01
LATEST ACTION
2019-01-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
LISINOPRILPrescription
LISINOPRIL 40MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 20MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 5MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 30MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 10MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 2.5MG · TABLET · ORAL
Approval history
2019-01-11Labeling · Supplement 53 · standardAP
2019-01-11Labeling · Supplement 56 · standardAP
2015-04-15Labeling · Supplement 39 · standardAP
2015-04-15Labeling · Supplement 43 · standardAP
2015-04-15Labeling · Supplement 38 · standardAP
2015-04-15Labeling · Supplement 44 · standardAP
2013-08-14Labeling · Supplement 35 · standardAP
2013-02-19Labeling · Supplement 29AP
2013-02-19Labeling · Supplement 27AP
2013-02-19Labeling · Supplement 31 · standardAP
2008-02-29Labeling · Supplement 24AP
2007-08-14Labeling · Supplement 19AP
2005-08-30Labeling · Supplement 10AP
2005-06-16Labeling · Supplement 7AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.